Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 238

The DOI matches its Crossref record.

Favorable Response to Human Adipose Tissue-Derived Mesenchymal Stem Cells in Steroid-Refractory Acute Graft-Versus-Host Disease

Fang, B., Song, Y., Liao, L., Zhang, Y., Zhao, R.C.·2007·Transplantation Proceedings
DOI 10.1016/j.transproceed.2007.08.103
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.transproceed.2007.08.103

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. Weisdorf, 1990, Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome, Blood, 75, 1024, 10.1182/blood.V75.4.1024.1024 · doi:10.1182/blood.v75.4.1024.1024
  2. Martin, 1991, A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment, Blood, 77, 1821, 10.1182/blood.V77.8.1821.1821 · DOI · Paper page
  3. Schiller, 1993, Is there an effective therapy for chronic graft-versus-host disease?, Bone Marrow Transplant, 11, 189
  4. Mookerjee, 1999, Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus, Bone Marrow Transplant, 24, 517, 10.1038/sj.bmt.1701936 · doi:10.1038/sj.bmt.1701936
  5. Vogelsang, 2001, How I treat chronic graft-versus-host disease, Blood, 97, 1196, 10.1182/blood.V97.5.1196 · doi:10.1182/blood.v97.5.1196
  6. Lazarus, 1995, Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use, Bone Marrow Transplant, 16, 557
  7. Koc, 2000, Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy, J Clin Oncol, 18, 307, 10.1200/JCO.2000.18.2.307 · DOI · Paper page
  8. Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci U S A, 99, 8932, 10.1073/pnas.132252399 · DOI · Paper page
  9. Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650 · DOI · Paper page
  10. Puissant, 2005, Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells, Br J Haematol, 129, 118, 10.1111/j.1365-2141.2005.05409.x · DOI · Paper page
  11. Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7 · DOI · Paper page
  12. Fang, 2006, Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells, Bone Marrow Transplant, 38, 389, 10.1038/sj.bmt.1705457 · doi:10.1038/sj.bmt.1705457
  13. Przepiorka, 1995, 1994 Consensus Conference on Acute GVHD Grading, Bone Marrow Transplant, 15, 825
  14. Cao, 2005, Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo, Biochem Biophys Res Commun, 332, 370, 10.1016/j.bbrc.2005.04.135 · DOI · Paper page
  15. Bacigalupo, 1983, High dose bolus methylprednisolone for the treatment of acute graft versus host disease, Blut, 46, 125, 10.1007/BF00320270 · doi:10.1007/bf00320270
  16. Khoury, 2001, Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin, Bone Marrow Transplant, 27, 1059, 10.1038/sj.bmt.1703032 · doi:10.1038/sj.bmt.1703032
  17. Wolff, 2005, Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept, Bone Marrow Transplant, 35, 1003, 10.1038/sj.bmt.1704929 · doi:10.1038/sj.bmt.1704929
  18. Ratanatharathorn, 2003, Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody, Biol Blood Marrow Transplant, 9, 505, 10.1016/S1083-8791(03)00216-7 · doi:10.1016/s1083-8791(03)00216-7
  19. Lee, 2003, Chronic graft-versus-host disease, Biol Blood Marrow Transplant, 9, 215, 10.1053/bbmt.2003.50026 · DOI · Paper page
  20. Reyes, 2001, Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells, Blood, 98, 2615, 10.1182/blood.V98.9.2615 · DOI · Paper page
  21. Fang, 2004, Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow, J Lab Clin Med, 143, 230, 10.1016/j.lab.2003.11.008 · DOI
  22. Zhao, 2005, Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo, Bone Marrow Transplant, 36, 355, 10.1038/sj.bmt.1705062 · DOI
  23. Hu, 2003, Isolation and identification of mesenchymal stem cells from human fetal pancreas, J Lab Clin Med, 141, 342, 10.1016/S0022-2143(03)00022-2 · DOI · Paper page
  24. Chen, 2006, Mesenchymal stem cells in immunoregulation, Immunol Cell Biol, 84, 413, 10.1111/j.1440-1711.2006.01458.x · DOI · Paper page
  25. Le Blanc, 2005, Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 11, 321, 10.1016/j.bbmt.2005.01.005 · DOI · Paper page
  26. Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X · DOI · Paper page
  27. Deng, 2004, Allogeneic bone marrow-derived flk-1+Sca-1− mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance, Exp Hematol, 32, 861, 10.1016/j.exphem.2004.06.009 · DOI
  28. Bensidhoum, 2004, Homing of in vitro expanded Stro-1− or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment, Blood, 103, 3313, 10.1182/blood-2003-04-1121 · DOI · Paper page
  29. Baudard, 2002, Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients, Bone Marrow Transplant, 30, 287, 10.1038/sj.bmt.1703633 · doi:10.1038/sj.bmt.1703633
  30. Kim, 2004, Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant, Eur J Haematol, 173, 56, 10.1111/j.1600-0609.2004.00247.x · doi:10.1111/j.1600-0609.2004.00247.x
  31. Remberger, 2001, Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin, Clin Transplant, 15, 147, 10.1034/j.1399-0012.2001.150301.x · doi:10.1034/j.1399-0012.2001.150301.x
  32. McCaul, 2000, Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin, J Hematother Stem Cell Res, 9, 367, 10.1089/15258160050079470 · doi:10.1089/15258160050079470
  33. Przepiorka, 2000, Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease, Blood, 95, 83, 10.1182/blood.V95.1.83 · DOI · Paper page
  34. Benito, 2001, Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease, Transplantation, 72, 1924, 10.1097/00007890-200112270-00010 · DOI · Paper page

Cited by

See all 238

Metadata

Authors
Fang, B., Song, Y., Liao, L., Zhang, Y., & Zhao, R. C.
Venue
Transplantation Proceedings
Publisher
Elsevier BV
Published
2007-12
Volume
39
Issue
10
Pages
3358-3362
ISSN
0041-1345 (ISSN-L)
DOI
10.1016/j.transproceed.2007.08.103
OpenAlex
W1986142040
Cited by
238
References
0
FWCI
7.76
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Favorable Response to Human Adipose Tissue-Derived Mesenchymal Stem Cells in Steroid-Refractory Acute Graft-Versus-Host Disease. https://app.cochat.ai/papers/10.1016/j.transproceed.2007.08.103
The paper
Fang, B., Song, Y., Liao, L., Zhang, Y., & Zhao, R. C. (2007). Favorable Response to Human Adipose Tissue-Derived Mesenchymal Stem Cells in Steroid-Refractory Acute Graft-Versus-Host Disease. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2007.08.103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.